Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease

Abstract Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a poor prognosis for survival. Risk factors include alcohol and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor immune responses immunotherapeutic approaches ar...

Full description

Saved in:
Bibliographic Details
Main Authors: Franziska Oliveri, Linda Neher, Ronja Pscheid, Isabel Sewald, Sowmya Gowdavally, Annika C. Betzler, Jaqueline Hallitsch, Jens Greve, Simon Laban, Sebastian Schmid, Thomas K. Hoffmann, Patrick J. Schuler, Cornelia Brunner
Format: Article
Language:English
Published: Springer 2025-01-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-024-03907-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850067576527257600
author Franziska Oliveri
Linda Neher
Ronja Pscheid
Isabel Sewald
Sowmya Gowdavally
Annika C. Betzler
Jaqueline Hallitsch
Jens Greve
Simon Laban
Sebastian Schmid
Thomas K. Hoffmann
Patrick J. Schuler
Cornelia Brunner
author_facet Franziska Oliveri
Linda Neher
Ronja Pscheid
Isabel Sewald
Sowmya Gowdavally
Annika C. Betzler
Jaqueline Hallitsch
Jens Greve
Simon Laban
Sebastian Schmid
Thomas K. Hoffmann
Patrick J. Schuler
Cornelia Brunner
author_sort Franziska Oliveri
collection DOAJ
description Abstract Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a poor prognosis for survival. Risk factors include alcohol and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor immune responses immunotherapeutic approaches are approved for recurrent metastatic disease but only approx. 20% of patients respond to checkpoint blockade of the PD-1/PD-L1 axis. Therefore, preclinical research is needed to better understand molecular and cellular processes and to identify new therapeutic targets. Immunocompetent mouse models can serve these purposes but only few are currently available for HPV-positive HNSCC. Here, we established a mouse cell line overexpressing the oncogenes E6/E7 of the HPV16 genome as well as a constitutively active form of H-Ras and studied the anti-tumor immune response upon orthotopic tumor growth at the floor of the mouth. Moreover, we analyzed the same immunoregulatory pathways in samples of HPV-positive cancer patients. T cells in the tumor of mice and humans exhibited high expression of CD39 and CD73, two ectoenzymes involved in the production of immunosuppressive adenosine from ATP, along with increased expression of PD-1, LAG-3 and GITR. Additionally, B cell responses were elevated in tumor-bearing mice, seen as an increase of germinal center, immunoregulatory marginal zone and follicular B cell subtypes. Taken together, this study suggests that the generated mouse model shares characteristics with human disease and can thus be used as a platform to study anti-tumor responses in HPV-positive HNSCC which will help to identify novel therapeutic targets.
format Article
id doaj-art-a2b6ec5edf084ee199f1b3f1255c5c9c
institution DOAJ
issn 1432-0851
language English
publishDate 2025-01-01
publisher Springer
record_format Article
series Cancer Immunology, Immunotherapy
spelling doaj-art-a2b6ec5edf084ee199f1b3f1255c5c9c2025-08-20T02:48:16ZengSpringerCancer Immunology, Immunotherapy1432-08512025-01-017421810.1007/s00262-024-03907-yCharacterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human diseaseFranziska Oliveri0Linda Neher1Ronja Pscheid2Isabel Sewald3Sowmya Gowdavally4Annika C. Betzler5Jaqueline Hallitsch6Jens Greve7Simon Laban8Sebastian Schmid9Thomas K. Hoffmann10Patrick J. Schuler11Cornelia Brunner12Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Anesthesiology and Intensive Care Medicine, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical CenterAbstract Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a poor prognosis for survival. Risk factors include alcohol and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor immune responses immunotherapeutic approaches are approved for recurrent metastatic disease but only approx. 20% of patients respond to checkpoint blockade of the PD-1/PD-L1 axis. Therefore, preclinical research is needed to better understand molecular and cellular processes and to identify new therapeutic targets. Immunocompetent mouse models can serve these purposes but only few are currently available for HPV-positive HNSCC. Here, we established a mouse cell line overexpressing the oncogenes E6/E7 of the HPV16 genome as well as a constitutively active form of H-Ras and studied the anti-tumor immune response upon orthotopic tumor growth at the floor of the mouth. Moreover, we analyzed the same immunoregulatory pathways in samples of HPV-positive cancer patients. T cells in the tumor of mice and humans exhibited high expression of CD39 and CD73, two ectoenzymes involved in the production of immunosuppressive adenosine from ATP, along with increased expression of PD-1, LAG-3 and GITR. Additionally, B cell responses were elevated in tumor-bearing mice, seen as an increase of germinal center, immunoregulatory marginal zone and follicular B cell subtypes. Taken together, this study suggests that the generated mouse model shares characteristics with human disease and can thus be used as a platform to study anti-tumor responses in HPV-positive HNSCC which will help to identify novel therapeutic targets.https://doi.org/10.1007/s00262-024-03907-yHead and neck cancerHPVImmune checkpointsTumor-infiltrating lymphocytes
spellingShingle Franziska Oliveri
Linda Neher
Ronja Pscheid
Isabel Sewald
Sowmya Gowdavally
Annika C. Betzler
Jaqueline Hallitsch
Jens Greve
Simon Laban
Sebastian Schmid
Thomas K. Hoffmann
Patrick J. Schuler
Cornelia Brunner
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
Cancer Immunology, Immunotherapy
Head and neck cancer
HPV
Immune checkpoints
Tumor-infiltrating lymphocytes
title Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
title_full Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
title_fullStr Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
title_full_unstemmed Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
title_short Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease
title_sort characterization of the adaptive immune response in a mouse model for hpv positive head and neck squamous cell carcinoma with implications to human disease
topic Head and neck cancer
HPV
Immune checkpoints
Tumor-infiltrating lymphocytes
url https://doi.org/10.1007/s00262-024-03907-y
work_keys_str_mv AT franziskaoliveri characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT lindaneher characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT ronjapscheid characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT isabelsewald characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT sowmyagowdavally characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT annikacbetzler characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT jaquelinehallitsch characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT jensgreve characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT simonlaban characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT sebastianschmid characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT thomaskhoffmann characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT patrickjschuler characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease
AT corneliabrunner characterizationoftheadaptiveimmuneresponseinamousemodelforhpvpositiveheadandnecksquamouscellcarcinomawithimplicationstohumandisease